Ultragenyx Pharmaceutical Inc. - COM (RARE)

Q2 2019 13F Holders as of 6/30/2019

Type / Class
Equity / COM
Number of holders
164
Total Shares
58.8M
Shares change
+802K
Total reported value, excl. options
$3.73B
Value change
+$49M
Put/Call ratio
0.78
Number of buys
95
Number of sells
-65
Price
$63.50
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.